Compugen (CGEN) Depreciation and Depletion (2009 - 2010)
Compugen (CGEN) reported Depreciation and Depletion of $50000.0 for Q4 2010, up 316.67% on a YoY basis from $12000.0 in Q4 2009, and down 1.96% sequentially from $51000.0 in Q3 2010.
Compugen (CGEN) Depreciation and Depletion (2009 - 2010) Analysis & Trends
Compugen (CGEN) has 2 years of Depreciation and Depletion data on file, last reported at $50000.0 in Q4 2010.
- For the quarter ending Q4 2010, Depreciation and Depletion rose 316.67% year-over-year to $50000.0; the trailing twelve-month figure through Dec 2010 stood at $161000.0 (changed N/A YoY), and the FY2025 full-year result was $475000.0, down 2.26% from the prior year.
- Depreciation and Depletion fell to $50000.0 in Q4 2010, from $51000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $51000.0 in Q3 2010 to a low of $12000.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 50,000.00 |
| Dec 31, 2010 | 50,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Sep 30, 2010 | 51,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Dec 31, 2009 | 12,000.00 |
| Sep 30, 2009 | 48,000.00 |
| Sep 30, 2009 | 48,000.00 |